C.O./CCO Curve Alert Messages

13 Monitoring Cardiac Output

C.O./CCO Curve Alert Messages

After each measurement trial, the monitor analyzes the thermodilution curve. If the curve appears abnormal, a curve alert message appears in the C.O. procedure window. A question mark symbol (“?”) may appear next to the cardiac output numeric if any of these messages appear. The curve alert messages are not error messages and do not necessarily mean that the measured values are invalid.

C.O./CCO Curve Alert Messages

Possible Causes

 

 

Tinj off scale

The Tinjectate is out of the range -1°C and 30°C. Cool down or heat

 

up the injectate or change the injectate solution and repeat the

 

measurement.

Noisy Baseline

A blood temperature baseline drift that could not be compensated

 

was detected during the C.O. measurement. Possible causes are:

 

- Interference may be caused by a ventilator.

 

- Interference may be caused by an infusion pump: infusions of

 

significant volume through the central line should be paused at least

 

30 seconds before the first thermodilution measurement in a series

 

and should not recommence until the measurement series is

 

completed.

 

- Do not administer injections through the central line during a

 

measurement series.

 

- Electrical devices in the vicinity can cause interference: check for

 

infusion pumps connected to the central catheter, cables parallel to

 

the thermodilution cable, electrocautery. Make sure all devices are

 

properly grounded.

 

- Wait until measurement results are displayed before moving the

 

patient or catheter.

 

- Close the stopcock to the injectate syringe after the injection.

 

- Do not rinse the catheter during measurement, to avoid

 

temperature fluctuations.

Temperature Baseline

May occur if patient is recovering from open heart surgery, or if

Drift

patient was cooled down for surgery and is in the process of regaining

 

normal body temperature when the measurement is made.

Small signal, more

The peak of the transpulmonary thermodilution curve was below

indicator required

0.1ºC. Increase injectate volume and/or lower injectate temperature.

Injectate Temperature

The difference between the blood and injectate temperatures is too

too High

small. The calculated value for C.O. may not be accurate.

High ETVI, use cold

The ETVI value is too high. The accuracy of the transpulmonary

injectate or greater

thermodilution measurement may be reduced. Increase injectate

inj. volume

volume and/or lower injectate temperature following the guidelines

 

given in the section “Guidelines for PiCCO C.O. Injectate” on

 

page 170.

Disturbed Injection

The injection should be performed quickly and with a steady

 

pressure. Shaking, unsteady pressure, or injections that take longer

 

than six seconds may cause this message to appear; you should bear

 

this in mind if you are using a large injectate volume (> 10 ml).

 

 

171

Page 191
Image 191
Philips MP40/50, MP60/70/80/90, MP20/30 manual CCO Curve Alert Messages, Possible Causes

MP60/70/80/90, MP40/50, MP20/30 specifications

Philips MP20/30, MP40/50, and MP60/70/80/90 are advanced patient monitoring systems designed to enhance clinical workflows and patient care in diverse healthcare settings. These devices combine cutting-edge technologies and user-friendly interfaces, making them essential tools for hospitals and healthcare providers.

The MP20 and MP30 are notable for their compact design, making them ideal for environments where space is limited. They come equipped with a variety of monitoring parameters, including ECG, SpO2, and non-invasive blood pressure, providing a comprehensive overview of patient health. These models are particularly suited for use in general wards or recovery areas, offering reliability and ease of use.

Moving to the MP40 and MP50, these monitors incorporate more advanced functionalities, including multi-gas monitoring, which is vital for anesthetic applications. They feature a robust data storage capacity, allowing for extensive patient history tracking and improved decision-making capabilities. The intuitive touchscreen interfaces facilitate quick access to essential information, enabling healthcare professionals to respond efficiently to changes in a patient's condition.

The MP60, MP70, MP80, and MP90 series represent the pinnacle of Philips' patient monitoring technology. These monitors are equipped with advanced algorithms that enhance the precision of vital sign measurements, including advanced ECG analysis capabilities that assist in detecting arrhythmias. The MP80 and MP90 models further integrate advanced monitoring technologies such as 3D visualization for hemodynamics and deep learning algorithms for early warning systems.

Connectivity is a key feature across the Philips monitoring range, with many models offering seamless integration with hospital information systems and electronic health records. This connectivity ensures that patient data is easily accessible to clinicians, promoting informed decision-making. Moreover, alarm management features are designed to minimize false alarms, significantly improving the staff's response time by focusing on critical alerts.

In summary, Philips MP20/30, MP40/50, MP60/70/80/90 monitors deliver exceptional monitoring capabilities, combining user-friendly design with advanced technology. Their varied features allow them to cater to different clinical needs, enhancing patient care and supporting healthcare professionals in their critical roles. With these monitors, healthcare facilities can achieve a new standard in patient monitoring, ensuring quality and safety in patient management.